NCT01250184

Brief Summary

Background: Myofascial pain syndrome (MPS) of the shoulder girdle and cervical region is a common musculoskeletal problem that is often chronic or recurrent. It has demonstrated the effectiveness of different treatments such as exercise, injection but not comparing them with each other. The objective of this research was to demonstrate whether lidocaine injection into trigger points combined with a physical therapy program was more effective than each separatetreatment in improving pain, function and quality of life in a group of patients with myofascial pain syndrome (MPS) of the shoulder girdle and cervical region. Design: Single-blind, randomized, controlled clinical trial with three parallel groups in the departments of physical medicine and rehabilitation of two urban hospitals. There were 127 patients with myofascial pain in the shoulder girdle for more than six weeks in length and pain greater than 40 mm on the visual analog scale (VAS). There were three intervention groups: physical therapy (PT), lidocaine injection (LI), or the combination of both (PT + LI). The primary outcome at one month was the VAS, and the secondary outcomes were measured using the SF36 pain scaleat one and three months. Keywords: Myofascial pain, trigger points, lidocaine injection, physical therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
127

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started May 2009

Typical duration for phase_4

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

November 27, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 30, 2010

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

October 10, 2014

Completed
Last Updated

October 10, 2014

Status Verified

October 1, 2014

Enrollment Period

2.1 years

First QC Date

November 27, 2010

Results QC Date

September 27, 2014

Last Update Submit

October 4, 2014

Conditions

Keywords

Myofascial painTrigger points.Lidocaine injection.Physical therapy

Outcome Measures

Primary Outcomes (2)

  • Visual Analogue Scale

    VAS with a score of 0-100, where 100 is the value representing the highest degree of pain and 0 the lowest. Successful treatment was defined as a reduction in pain of at least 20% of the previous score on the VAS after 4 weeks of the initial evaluation, or 14 mm on the VAS; this scale is a reliable pain assessment measure that has been validated previously

    4 weeks

  • Visual Analogue Scale

    VAS with a score of 0-100, where 100 is the value representing the highest degree of pain and 0 the lowest. Successful treatment was defined as a reduction in pain of at least 20% of the previous score on the VAS after 4 weeks of the initial evaluation, or 14 mm on the VAS; this scale is a reliable pain assessment measure that has been validated previously

    12 weeks

Secondary Outcomes (4)

  • PHQ 9 Function Measured With the Hand Back and Hand Mouth Maneuvers. Complications and Adverse Reactions Need for Rescue Medication

    4 weeks

  • Quality of Life SF-36

    4 weeks

  • PHQ 9 Function Measured With the Hand Back and Hand Mouth Maneuvers. Complications and Adverse Reactions Need for Rescue Medication

    12 weeks

  • Quality of Life SF-36

    12 weeks

Study Arms (3)

Physical Therapy

ACTIVE COMPARATOR

Twelve sessions, 3 per week.

Other: Physical therapy

Lidocaine injection

ACTIVE COMPARATOR

Blocking the myofascial trigger point (MTP) with lidocaine injection, unique dose.

Drug: Lidocaine injection

Lidocaine injection + physical therapy

EXPERIMENTAL

Blocking the Myofascial trigger point (MTP) with lidocaine injection plus a standarized therapeutic exercise program, twelve sessions, 3 per week.

Other: Lidocaine injection + physical therapy

Interventions

Twelve sessions (3 per week)

Also known as: standardized therapeutic exercise program
Physical Therapy

blocking the Myofascial trigger point (MTP) with lidocaine injection, unique dose.

Also known as: blocking the Myofascial trigger point
Lidocaine injection

blocking the Myofascial trigger point (MTP) with lidocaine injection plus a standarized therapeutic exercise program (twelve sessions, 3 per week)

Also known as: blocking plus a standarized therapeutic exercise program
Lidocaine injection + physical therapy

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Cervical Pain at least six weeks
  • At least 40 mm in the VAS
  • They cannot been received treatment like physical therapy or analgesics
  • Maximum score of PHQ 16 points

You may not qualify if:

  • Depression
  • Fibromyalgia
  • Cervical Radiculopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Clinica de Las Américas

Medellín, Antioquia, Colombia

Location

Ips Universitaria

Medellín, Antioquia, Colombia

Location

MeSH Terms

Conditions

Myofascial Pain SyndromesPainMusculoskeletal Pain

Interventions

Physical Therapy ModalitiesLidocaine

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitationAcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Limitations and Caveats

The therapists were not the same throughout the investigation, however all were standardized to interventions; especilaistas doctors who applied the injections were different. No specific measure of patient-centered operation is used.

Results Point of Contact

Title
Dr. Luz Helena Lugo, Head of Research Group Rehabilitation in Health
Organization
university of Antioquia, Research Group Rehabilitation in Health

Study Officials

  • Luz H Lugo Agudelo, Professor

    Universidad de Antioquia Grupo Rehabilitacion en Salud

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 27, 2010

First Posted

November 30, 2010

Study Start

May 1, 2009

Primary Completion

June 1, 2011

Study Completion

September 1, 2011

Last Updated

October 10, 2014

Results First Posted

October 10, 2014

Record last verified: 2014-10

Locations